CL — Colgate-Palmolive Co Balance Sheet
0.000.00%
- $63.95bn
- $71.64bn
- $20.10bn
- 89
- 44
- 40
- 60
Annual balance sheet for Colgate-Palmolive Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 925 | 866 | 950 | 1,145 | 1,256 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,264 | 1,297 | 1,504 | 1,586 | 1,521 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,338 | 4,397 | 5,113 | 5,279 | 5,317 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,237 | 4,257 | 4,785 | 5,073 | 4,951 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 15,920 | 15,040 | 15,731 | 16,393 | 16,046 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,404 | 4,051 | 4,004 | 4,741 | 5,759 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 15,177 | 14,431 | 15,330 | 15,784 | 15,834 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 743 | 609 | 401 | 609 | 212 |
| Total Liabilities & Shareholders' Equity | 15,920 | 15,040 | 15,731 | 16,393 | 16,046 |
| Total Common Shares Outstanding |